FERRARI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.977
EU - Europa 416
AS - Asia 199
Totale 2.592
Nazione #
US - Stati Uniti d'America 1.976
IT - Italia 255
CN - Cina 81
SG - Singapore 68
VN - Vietnam 45
FI - Finlandia 40
SE - Svezia 33
FR - Francia 21
GB - Regno Unito 21
DE - Germania 17
IE - Irlanda 12
NL - Olanda 7
CZ - Repubblica Ceca 4
AT - Austria 2
RO - Romania 2
CA - Canada 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
OM - Oman 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 2.592
Città #
Fairfield 375
Ashburn 183
Woodbridge 175
Houston 159
Seattle 147
Cambridge 143
Chandler 121
Wilmington 104
Ann Arbor 100
Padova 53
Singapore 52
Santa Clara 51
Boardman 46
Dong Ket 45
San Diego 39
Medford 36
Princeton 35
Des Moines 33
Helsinki 27
Milan 26
Roxbury 23
Rome 19
Beijing 12
Dublin 12
Washington 10
Turin 9
Cagliari 7
London 7
Norwalk 6
Bari 4
Crotone 4
Guardiagrele 4
Hebei 4
Jinan 4
Olomouc 4
Azzano San Paolo 3
Bitonto 3
Florence 3
Mainz 3
Nanjing 3
Orta di Atella 3
San Severino Marche 3
Sant'Eufemia d'Aspromonte 3
Sesto Fiorentino 3
Shenyang 3
Amsterdam 2
Bologna 2
Bolzano 2
Brescia 2
Bucharest 2
Buti 2
Castelbuono 2
Chicago 2
Chiswick 2
Chongqing 2
Correggio 2
Corte Franca 2
Dallas 2
Fasano 2
Genoa 2
Grammichele 2
Groningen 2
Hefei 2
Jiaxing 2
Kilburn 2
Loria 2
Los Angeles 2
Lumezzane 2
Mezzano 2
Mezzomerico 2
Modugno 2
Naples 2
New Bedfont 2
New York 2
Newark 2
Novi Ligure 2
Orange 2
Paduli 2
Palazzolo sull'Oglio 2
Pavia 2
Sabaudia 2
Spinea 2
Tianjin 2
Trieste 2
Venezia 2
Venice 2
Avellino 1
Buffalo 1
Changsha 1
Chengdu 1
Fairfax 1
Foggia 1
Fontenay-sous-bois 1
Gunzenhausen 1
Jakarta 1
Kish 1
Kunming 1
Laureana di Borrello 1
Melzo 1
Mestre 1
Totale 2.205
Nome #
Aspetti clinici, epidemiologici e genetici delle diverse forme di trombocitopenie ereditarie 247
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 197
Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients 131
A novel germ-line mutation of c-mpl gene in a sporadic case of essential thrombocythemia 123
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma 106
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected 102
The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance 102
Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study 101
Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders 88
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX) 88
A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome 88
Thrombotic events in homozygotes with a proven or highly probable Arg304Gln Factor VII mutation (FVII Padua) 1): only limited replacement therapy is needed in case of surgery 81
Thrombotic events in severe FXII deficiency in comparison with unaffected family members during a long observation period 80
Pathogenetic Role of Factor VII Deficiency and Thrombosis in Cross-Reactive Material Positive Patients 76
The story of serum prothrombin conversion accelerator, proconvertin, stable factor, cothromboplastin, prothrombin accelerator or autoprothrombin I, and their subsequent merging into factor VII 75
Congenital FXI and FVII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: an intriguing observation. 73
Drug-Induced Thrombophilic or Prothrombotic States: An Underestimated Clinical Problem That Involves Both Legal and Illegal Compounds 71
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 68
A family with factor x deficiency from Argentina: a compound heterozygosis due to the combination of a new mutation (Gln138Arg) with an already known one (Glu350Lys) 63
New data on FII, FV, FIX and thrombomodulin defects: blood keeps clotting in normal and in peculiar ways 53
African and African-American Contribution to the Knowledge of the FVII Padua (Arg304Gln) Defect 53
Acquired Isolated FVII Deficiency An Underestimated and Potentially Important Laboratory Finding. 49
Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched vs 128 unaffected family members, during a long sequential observation period (23.5 years). 47
Factor X Friuli coagulation disorder: Almost 50 Years Later 46
Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed 43
A structure–function analysis in patients with prekallikrein deficiency 41
Bleeding manifestations in heterozygotes with prothrombin deficiency or abnormalities vs. unaffected family members as observed during a long follow-up study 40
Bleeding manifestations in heterozygotes with congenital FVII deficiency: a comparison with unaffected family members during a long observation period* 40
New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice 40
Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation 38
Myocardial Infarctions and Other Acute Coronary Syndromes in Rare Congenital Bleeding Disorders: A Critical Analysis of All Reported Cases. 35
Role of replacement therapy in the evaluation of thrombosis occurring in congenital bleeding conditions 35
Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United States 34
Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis 33
Prevalence of hypertension and its complications in congenital Prekallikrein deficiency: analysis of all reported cases and clinical significance. 32
Cardiovascular diseases in congenital prekallikrein deficiency: Comparison with other chanceassociated morbidities 31
The Lesson Learned from the New c.2547-1G>T Mutation Combined with p.R854Q: When a Type 2N Mutation Reveals a Quantitative von Willebrand Factor Defect 11
Totale 2.661
Categoria #
all - tutte 11.312
article - articoli 10.548
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.860


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020372 0 0 0 0 47 24 41 58 104 46 43 9
2020/2021509 43 29 35 30 5 9 8 47 106 62 74 61
2021/2022454 3 31 58 3 37 66 16 35 51 23 31 100
2022/2023322 72 18 15 31 60 45 1 11 40 3 21 5
2023/2024333 5 22 59 23 37 50 33 25 10 11 22 36
2024/2025238 13 37 55 41 92 0 0 0 0 0 0 0
Totale 2.661